Navigation Links
IR BioSciences Announces Data Demonstrating Radilex Stimulation of,Stem Cells Results in Hematopoietic Recovery Following Lethal,Irradiation

Animal Data Shows Prolonged Survival AND Increased Platelet Concentrations

SCOTTSDALE, Ariz., March 08, 2007 /PRNewswire-FirstCall/ -- ImmuneRegen BioSciences, a wholly-owned subsidiary of IR BioSciences Holdings, Inc. announced today that ongoing analysis of data acquired from previously performed animal efficacy studies has revealed evidence that ImmuneRegen's developmental stage product, Radilex(TM), may stimulate hematopoietic stem cells.

Studies performed at the Oak Ridge National Laboratory reveal that ImmuneRegen's potential radioprotectant product, Radilex, not only prolonged survival of animals exposed to lethal gamma irradiation, but appeared to have increased platelet concentrations in surviving animals. As the experimental protocol required these animals to be subject to repeated blood sampling as well as irradiation, saline injections were relied on for plasma volume restoration. In the face of the resulting hemodilution, compensatory hematopoietic mechanisms were nonetheless adequately stimulated to enable survival of a number of Radilex-treated, but no untreated, animals. Blood cell quantitation showed trends in the surviving animals toward neutrophil replenishment as well. ImmuneRegen has since filed a provisional patent entitled "Method to Treat Blood Cell Depletion" to provide intellectual property protection for this finding regarding Radilex.

Continuing radiation studies will be performed at both the Translational Genomics Research Institute (TGen) and TGen Drug Development Services (TD2, its drug development arm) and at the Pacific Northwest National Laboratory to further explore the impact of radiation on the hematopoietic system of Radilex-exposed animals. ImmuneRegen's ongoing studies will be designed to examine mechanistic indicators at both high levels of radiation where Radilex has shown protection, as well as at lower levels. If successful, these studies will enable Rad
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
2. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
3. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
4. IR BioSciences Announces Promising Data from Study of Its Compound Homspera
5. Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data From Nerve Regeneration Program at American Society for Neural Therapy and Repair Meeting
6. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
7. ImmuneRegen BioSciences Announces Promising Data on Homspera Suggesting Potential as a Co-Therapeutic Agent
8. Study in Cell by Magen BioSciences Co-Founder David E. Fisher Identifies New Roles in Skin Cancer Prevention for Key Tumor Suppressor Protein
9. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
10. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis

Post Your Comments:
(Date:11/23/2009)...--Reportlinker.comannouncesthatanewmarketresearchr...onSystems&Equipment-AGlobalMarketPerspective ...lization-Systems--Equipment---A-Global-Market-Pers...pr&utm_campaign=prnewswire ,, Steamster...dprocedure.Steamsterilizationmarketisstableduetore...
(Date:11/23/2009)...ire/--BridgePointMedicalannouncedtodaythatitreceiv...yandperipheralChronicTotalOcclusion(CTO)CrossingSy...andtheStingray®CTORe-EntrySystem.TheBridgePoi...esignedtonavigatehighlydiseasedarteriesinpreparati.... ,, TheNationalHeart,LungandBloodInstitute(NHL...
(Date:11/23/2009)...PRNewswire-FirstCall/-- LexiconPharmaceuticals,Inc...omitsPhase2clinicalstudywith LX1031 inpatientswith...resentedatGASTRO2009inLondonthisweek.Resultsfromth...toms,willbepresentedbyDr. PhilipM.Brown ,Lexicon,s...r25,2009at2:30pmlocaltimeatthesessionentitled,"The...
Breaking Medicine Technology:Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 2Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 3Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 4Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 5Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 6Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 7BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3Curing Diabetes Pigs Turn to Lions 50180 1Curing Diabetes Pigs Turn to Lions 50180 2Curing Diabetes Pigs Turn to Lions 50180 3Tryptophan deficiency may underlie quinine side effects 9022 1Tryptophan deficiency may underlie quinine side effects 9022 2 C O R R E C T I O N Agendia B V 4656 1 C O R R E C T I O N Agendia B V 4656 2 C O R R E C T I O N Agendia B V 4656 3
..., May 2 /PRNewswire-FirstCall/ -- MedImmune, Inc.,...s will be,presented at the 2007 Pediatric Academic... company,s commitment to advancing the,science of ...ng to,MedImmune,s approved and development-stage p...vaccines targeting respiratory infectious,diseases...
...2007—The drug levosimendan did not improve,s...ure when,compared with a more widely-used treatmen...tudy in the May 2 issue of, JAMA . , Acute decompe...haracterized by inability of the heart to maintain...e of hospitalization worldwide,but appropriate tr...
Other Medicine Technology:Pediatric Academic Societies' Annual Meeting to Feature Data,Presentations Related to MedImmune Clinical Programs in Influenza,RSV and hMPV 2Pediatric Academic Societies' Annual Meeting to Feature Data,Presentations Related to MedImmune Clinical Programs in Influenza,RSV and hMPV 3Pediatric Academic Societies' Annual Meeting to Feature Data,Presentations Related to MedImmune Clinical Programs in Influenza,RSV and hMPV 4Drug for Treatment of Heart Failure Does Not Improve Survival,Compared to More Widely-used Medication 2
(Date:11/23/2009)...INGTON,Nov.23/PRNewswire-USNewswire/-- The Americ...gestindividualmembershipassociationofstatelegislat...TimScott forpre-filinga constitutionalamendment to...rechoices.SouthCarolinanowbecomesthe24thstatewhere...ionmodeledafterALEC,s FreedomofChoiceinHealthCareA...
(Date:11/23/2009)...ORK,Nov.23/PRNewswire/--Howistheeconomyaffectingpe...;SaatchiWellnessonWellness&theEconomy,theecono...sfromahealthylifestyleofexerciseanddiettoonethatis...te. ,, Thesurvey,smostdramaticfindingwasthechan...matraditionalfocusonhealthandwellbeingtotoday,smor...
(Date:11/23/2009)...3, 2009 -- Exposure shortly after birth to ambient...d particles from diesel emissions are associated w...ren, according to a new study by researchers at th...lth (CCCEH) at Columbia University,s Mailman Schoo...lyze the effects of exposure to airborne metals in...
(Date:11/23/2009)... Plastic and Reconstructive Surgery.....eep you updated on the most current journal news f...btain any of the full studies highlighted here, or...se contact ASPS Public Relations at (847) 228-9900... (Vocus) November 23, 2009 -- Yes, Plastic S...
(Date:11/23/2009)...ORK,Nov.23/PRNewswire/-- ,, Reportlinker.comann...catalogue. ,, http://www.reportlinker.com/p01...e-to-Markets-Products-and-Innovation-2nd-Edition.h...m_campaign=prnewswire ,, Despitethegrowingatt...enremainasignificantconsumergroupthatcannotbeoverl...
Breaking Medicine News(10 mins):Health News:South Carolina Now 24th State to Defend Health Care Choice 2Health News:Being Well Is About Reinvention - Not Health 2Health News:Being Well Is About Reinvention - Not Health 3Health News:Exposures to metals and diesel emissions in air linked to respiratory symptoms in children 2Health News:Plastic and Reconstructive Surgery...In Brief 2Health News:Plastic and Reconstructive Surgery...In Brief 3Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 2Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 3Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 4Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 5Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 6Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 7
...balala-Msimang said that the traditional-medicines...health's budget. A workshop was conducted on tradi...he would set up an interim traditional-health coun... that there is a great deal of literature on tradi...
...te for Rahul Mahajan to be taken to a government h...en to Apollo hospital and not to AIIMS or Safdarja... the scene of overdosing. //But medical experts sa... Dr J.N. Pande, internal medicine expert and f...
... (NIST) researchers have demonstrated a new techni... which vary in a controlled fashion across a test ...at it can be applied to surface science experiment...ir chemical composition changes gradually across t...
...onde and Jehangir Sabavala displayed their work on...rary Indian paintings and sculptures held at Durba...e having a cultural co-operation between Indian an...y of Modern Art (NGMA) New Delhi. Initially ...
... 20th annual Winnemucca Mule Races, Show & Draft H...al competition between clones each one won their q...dollars competition on Sunday in U.S they lost to ...n 21.246 seconds, and finished third while Idaho S...
...ptor could turn out to be an important therapeutic...//other target tissues like uterus and prostate ti...y advance the understanding of the effects of estr...eek in an advanced online edition of the Proceedin...
Other Medicine News:Health News:The myth about government hospitals 2Health News:New Technique For Science Experiments 2Health News:Functional Differences In Estrogen Receptor Could Be A Therapeutic Target 2Health News:Functional Differences In Estrogen Receptor Could Be A Therapeutic Target 3
...L Capillary Blood Collection Tubes are 100% plasti...r a wide range of applications, the Capillary Coll...be, attached cap and a micro tube.,The capill...nto the micro tube thereby eliminating the tendenc...
...L Capillary Blood Collection Tubes are 100% plasti...r a wide range of applications, the Capillary Coll...be, attached cap and a micro tube.,The capill...nto the micro tube thereby eliminating the tendenc...
...L Capillary Blood Collection Tubes are 100% plasti...r a wide range of applications, the Capillary Coll...be, attached cap and a micro tube.,The capill...nto the micro tube thereby eliminating the tendenc...
...L Capillary Blood Collection Tubes are 100% plasti...r a wide range of applications, the Capillary Coll...be, attached cap and a micro tube.,The capill...nto the micro tube thereby eliminating the tendenc...
Medicine Products: